Pharmacology: Anti-coagulant/Antiplatelet Flashcards
What are the two classes of Anti-thrombotic drugs ?
Anti-Platelets
Anti-Coagulants
Where do ‘White Thrombi’ form and what are they primarily composed of ?
arteries (high flow conditions)
Platelets predominate
Relatively little fibrin
What class of medications would you use to control White Thrombi in the arterial system ?
Anti-Platelets (white thrombi are predominantly composed of platelets. Inhibiting their activation and aggregation will limit White Thrombus formation)
Where do Red Thrombi form and what are they primarily made of ?
in veins (slow flow conditions)
Rich in fibrin and trapped red blood cells
Relatively few platelets
Which class of drugs would you use to control Red Thrombi in the veinous system ?
Anti-Coagulants (They are predominantly fibrin, if you can block fibrin formation, you will have less Red Thrombi formation)
What is the conceptual difference between and Anti-thrombotic drug and a Thrombolytic drug ?
Anti-thrombotic drugs stop thrombi from forming
Thrombolytics break up pre-formed thrombi.
What are the three important processes that occur leading to ‘platelet plug’ formation ?
Platelet adhesion
Platelet activation (and secretion)–> due to mediator release (from granules and de novo synthesis and secretion)
Platelet aggregation
List effector molecules that lead to platelet activation:
Strongest: Collagen,Thrombin, PAF(Platelet Activating Factor)
Weaker:ADP, TxA2, Vassopressin
Weakest:Epi, Serotonin
What occurs to a platelet once it is activated ?
Once the platelet is activated, there is a conformational change in GP IIB/IIIA which allows platelets to bind fibrinogen–> Aggregation
Caveat: GP-IIB /IIIA antagonist inhibit the ability of platelets (activated) to bind firbrinogen. VERY EFFECTIVE anti-platelet drugs.
Anti-coagulant drugs stop which important thrombi molecule from forming ?
Fibrin ( Fibrinogen –> Fibrin)
The Prothrombin Time (PT) is used to measure the effectiveness of Anti-coagulant drugs. Which branch of the coagulation cascade is tested by PT : Intrinsic or Extrinsic ? Which drug is this typically used to test the efficacy of ?
Extrinsic (and Common)
(Factor VII is the beginning molecule. Usually activated due to trauma.)
Warfarin
The Activated Partial Thromboplastin time (aPTT) is used to measure the effectiveness of Anti-coagulant drugs. Which branch of the coagulation cascade is tested by aPTT: Intrinsic or Extrinsic ? What drug is this test specifically designed to test the efficacy of ?
Intrinsic (and Common)
(Factor XII is the starting point, typically activated by internal events.)
Unfractionated heparin: activates anti-thrombin III –> Decreased coagulation.
The Factor Xa inhibition assay is used to test the efficacy of which drug ? When is this drug often given in place of Warfarin ?
Low-molecular- weight heparin (LMWH) …Not used frequently since LMWH really doesn’t need to be monitored.
Pregnancy (patients who need to be decoagulated and are pregnant cannot take Warfarin since it is teratogenic)
The International normalized ratio (INR) is used to normalize the variability in which test for anti-coagulation efficacy ?
Prothrombin Time (PT)
The INR corrects for differences in the thromboplastin reagents used by different laboratories
Tissue-typePlasminogen Activator (tPA) is part which class of drug ?
Fibrionlytic (degrade pre-formed platelet plugs/thrombi)
What does tPA activate that leads to fibrinolytic activity ?
tPA activates fibrin bound PLASMINOGEN which leads to its activation to PLASMIN (tPA binds directly to Fibrin)
Plasmin is an enzyme which cleaves fibrin –> breakdown of clots.
Streptokinase and Urokinase are also fibrinolytic drugs. What is the main difference in these drugs from tPA ?
They are not fibrin specific drugs. They bind free fibrinogen as well as clot bound fibrin.
Reteplase (r-PA) and Tenecteplase (TNK-t-PA) are found in what class of drugs ?
Fibrinolytics ( Just like tPA and Uro/Streptokinase.)
If you wish to keep a patients clots intact, what can you give to stop plasminogen from being activated to plasmin ? What drugs will this affect ?
Plasminogen Activator Inhibitor I/II (Stops the formation of Plasmin.)
tPA, Uro/Streptokinase and Reteplase (r-PA)
Tenecteplase (TNK-t-PA)
What can you give to inhibit Plasmin from cleaving fibrin ?
Alpha2-Anti-plasmin. Inhibits formed plasmin from degrading fibrin
LIST (5) the main Anti-Platelet drugs (Stop platelet adhesion, activation and aggregation) ?
Aspirin (COX inhibitor) P2Y12 (ADP)receptor blockers Thienopyridines Non-thienopyridine (Plasogril) GP IIb/IIIa inhibitors Dipyridamole Cilostazol
Aspirin irreversibly inhibits COX. What platelet activator will be inhibited by this action ?
Thromboxane A2 (TxA2)
Which 3 group of patients should you think twice about giving Aspirin to ?
Patients with ASA allergy
Patients with Asthma and Nasal Polyps
Patients who may have to have surgery in the near future (5 days. May inhibit ability to clot post procedure)
List the adverse effects seen with ASA ?
GI upset (Most common)
ASA allergy
GI mucosal inflammation or erosion (Ulcer)
GI bleeding
Hemorrhagic strokes (decreased clotting ability)
Asthma exacerbation (esp. w/ nasal polyps) **
Tinnitus (ASA toxicity) **
Ringing in the ears